Rare diseases
Investigational molecules
Locations
Study of RLY-4008 for Patients with Cholangiocarcinoma and Other Advanced Solid Tumors
GermanyStudy of Emavusertib for Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome
GermanyStudy of Elranatamab for Patients with Multiple Myeloma Resistant to Proteasome Inhibitors, Immunomodulatory Drugs, and Anti-CD38 Antibodies
GermanyStudy of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
GermanyStudy on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment
GermanyStudy Comparing BI 907828 and Doxorubicin for Patients with Advanced Dedifferentiated Liposarcoma
GermanyStudy of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy
GermanyStudy of Tirzepatide for Reducing Obesity and Related Health Issues in Adolescents
GermanyStudy of deucravacitinib in adults with plaque psoriasis: Effects on immune system cells
GermanyStudy on the Effectiveness of OPT-302 and Ranibizumab for Patients with Wet Age-related Macular Degeneration
GermanyStudy of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older
GermanyStudy on the Effects of Efgartigimod Alfa for Patients with Generalized Myasthenia Gravis
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
